Phase II trial evaluating efficacy and safety of PRX-003 in patients with inflammatory diseases
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Imaprelimab (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- 01 Oct 2016 New trial record
- 29 Sep 2016 According to Prothena Corporation media release, developmental strategy will be discussed today in a webcast.